Literature DB >> 27614427

Epidemiological characterization of Acinetobacter baumannii bloodstream isolates from a Chinese Burn Institute: A three-year study.

Guangtao Huang1, Supeng Yin1, Lijuan Xiang2, Yali Gong1, Kedai Sun1, Xiaoqiang Luo1, Cheng Zhang1, Zichen Yang1, Liuyang Deng1, Bei Jiang1, Shouguang Jin3, Jing Chen1, Yizhi Peng4.   

Abstract

Acinetobacter baumannii infection is a serious threat to burn patients. Bacteremia due to A. baumannii is becoming the most common cause of mortality following burn. However, the epidemiology of A. baumannii causing burn-related bloodstream infections has rarely been reported. We retrospectively collected 81 A. baumannii isolates from the bloodstream of burn patients over a three-year period. Antibiotic susceptibility tests, the prevalence of antibiotic-resistant genes and sequence typing (ST) were conducted to characterize these strains. Most of the isolates showed an extensive drug-resistant phenotype. The resistance frequencies to imipenem and meropenem were 94% and 91%, respectively. The blaOXA-23-like gene, AmpC, IS-AmpC, PER and SIM are the five most prevalent resistant genes, and their prevalence rates are 93% (75/81), 86% (70/81), 73% (59/81), 73% (59/81) and 52% (42/81), respectively. The 81 isolates were grouped into 10 known and 18 unknown ST types, with ST368 (38%) being the most prevalent. Except for ST457 and four new types (STn2, STn6, STn11 and STn14), the remaining 23 ST types belonged to one clonal complex 92, which is most common among clinical isolate in China. The above results indicated that ST368 isolates possessing both the blaOXA-23-like gene and ampC gene were the main culprits of the increasing nosocomial A. baumannii infection in this study. More attention should be paid to monitoring the molecular epidemiology of A. baumannii isolates from burn patients to prevent further distribution. Such information may help clinicians with therapeutic decisions and infection control in the Burns Institute.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Acinetobacter baumannii; Bacteremia; Extended drug-resistant; Multilocus sequence typing (MLST); β-lactam

Mesh:

Substances:

Year:  2016        PMID: 27614427     DOI: 10.1016/j.burns.2016.02.021

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  6 in total

1.  Rapid and accurate detection of carbapenem-resistance gene by isothermal amplification in Acinetobacter baumannii.

Authors:  Shuang Liu; Guangtao Huang; Yali Gong; Xiaojun Jin; Yudan Meng; Yizhi Peng; Junning Zhao; Xiaolu Li; Qin Li
Journal:  Burns Trauma       Date:  2020-09-02

2.  Bacterial and antimicrobial susceptibility profile and the prevalence of sepsis among burn patients at the burn unit of Cipto Mangunkusumo Hospital.

Authors:  A Wardhana; R Djan; Z Halim
Journal:  Ann Burns Fire Disasters       Date:  2017-06-30

3.  Lytic Bacteriophage Screening Strategies for Multidrug-Resistant Bloodstream Infections in a Burn Intensive Care Unit.

Authors:  Zichen Yang; Yunlong Shi; Cheng Zhang; Xiaoqiang Luo; Yu Chen; Yizhi Peng; Yali Gong
Journal:  Med Sci Monit       Date:  2019-11-06

4.  Different Infection Profiles and Antimicrobial Resistance Patterns Between Burn ICU and Common Wards.

Authors:  Yali Gong; Yuan Peng; Xiaoqiang Luo; Cheng Zhang; Yunlong Shi; Yixin Zhang; Jun Deng; Yizhi Peng; Gaoxing Luo; Haisheng Li
Journal:  Front Cell Infect Microbiol       Date:  2021-06-30       Impact factor: 5.293

5.  Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study.

Authors:  Yangmin Hu; Danyang Li; Lingcheng Xu; Yuping Hu; Yiwen Sang; Gensheng Zhang; Haibin Dai
Journal:  Antimicrob Resist Infect Control       Date:  2021-06-30       Impact factor: 4.887

6.  Characterization of carbapenem-resistant hypervirulent Acinetobacter baumannii strains isolated from hospitalized patients in the mid-south region of China.

Authors:  Jun Li; Ting Yu; Yi Luo; Jing-Yi Peng; Yu-Jia Li; Xiao-Yan Tao; Yong-Mei Hu; Hai-Chen Wang; Ming-Xiang Zou
Journal:  BMC Microbiol       Date:  2020-09-14       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.